Cathy Gwin
Senior Director, Communications
Dr. Emily Leproust, the CEO and co-founder of Twist Bioscience, has joined the Board of Directors of the Nuclear Threat Initiative.
NTI | bio hosted an event on Capitol Hill to discuss how Congress and other key decisionmakers can take action to provide necessary oversight to safeguard biotechnologies, without stifling innovation in the field.
New study published in BMJ Global Health finds the pandemic was less deadly in countries that rank high on the Global Health Security Index.
NTI | bio, the Next Generation for Global Health Security (GHS) Network, the iGEM Foundation, 80,000 Hours, SynBio Africa, and the Global Health Security Network (GHSN) have launched the seventh Next Generation for Biosecurity Competition.
NTI | bio played a key role in shaping and leading biosecurity discussions at the event, including through events that highlighted the importance of protecting bioscience and biotechnology advances so society can reap their benefits, while guarding against accidental or deliberate misuse.
Sign up for our newsletter to get the latest on nuclear and biological threats.
Sign up for regular updates on innovative, real-world solutions to existential threats.
{ location = 'https://www.nti.org/get-updates/' }, 300);">Get Updates